Synthaverse S.A. Logo

Synthaverse S.A.

BML | WAR

Overview

Corporate Details

ISIN(s):
PLBMDLB00018 (+3 more)
LEI:
259400OWZM67D079S374
Country:
Poland
Address:
LUBLIN UNIWERSYTECKA 10, 20-029 LUBLIN
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Synthaverse S.A. is a pharmaceutical and biotechnology company with a history dating back to 1944. The company develops, manufactures, and sells medicinal products (both prescription and OTC), medical devices, and laboratory reagents. Its portfolio focuses on treatments in the areas of oncology, hematology, and immunology, with products sold in approximately 50 countries. Key brands include Onko BCG, a drug for bladder cancer, and the BCG 10 anti-tuberculosis vaccine, for which the company is the sole supplier in Poland. Synthaverse emphasizes the use of its own proprietary technologies and close cooperation with scientific centers to drive research and innovation.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Synthaverse S.A.. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-01 11:16
Declaration of Voting Results & Voting Rights Announcements
zal01_ESPI-wykaz-akcjonariuszy-posiadajacych-co-najmniej-5-glosow-na-NWZA-31.07…
Polish 142.0 KB
2025-08-01 11:16
Declaration of Voting Results & Voting Rights Announcements
Wykaz akcjonariuszy posiadających co najmniej 5% głosów na Nadzwyczajnym Walnym…
Polish 351 bytes
2025-08-01 11:10
Post-Annual General Meeting Information
zal01_UCHWALY_PODJETE_NWZA_31.07.2025.pdf
Polish 247.2 KB
2025-08-01 11:10
Declaration of Voting Results & Voting Rights Announcements
Treść uchwał podjętych przez Nadzwyczajne Walne Zgromadzenie Emitenta w dniu 31…
Polish 1.1 KB
2025-07-14 17:47
Board/Management Information
Rozszerzenie składu zarządu Spółki Synthaverse S.A. - Content (PL)
Polish 4.9 KB
2025-07-09 17:51
Major Shareholding Notification
zal01_FormularzF.pdf
Polish 89.4 KB
2025-07-09 17:51
Major Shareholding Notification
Znaczne pakiety akcji - zmiana w ogólnej liczbie głosów - Content (PL)
Polish 669 bytes
2025-07-08 17:47
Major Shareholding Notification
zal01_FormularzA_ponizej_5_proc.pdf
Polish 77.8 KB
2025-07-08 17:47
Major Shareholding Notification
zal02_FormularzA_powyzej_5_proc.pdf
Polish 77.8 KB
2025-07-08 17:47
Major Shareholding Notification
Znaczne pakiety akcji - zmiana w ogólnej liczbie głosów - Content (PL)
Polish 529 bytes
2025-07-08 16:12
Major Shareholding Notification
zal01_Zawiadomienie_o_stanie_posiadania.pdf
Polish 374.5 KB
2025-07-08 16:12
Major Shareholding Notification
Znaczne pakiety akcji - zmiana w ogólnej liczbie głosów. - Content (PL)
Polish 481 bytes
2025-07-08 09:37
Major Shareholding Notification
zal01_FormularzA.pdf
Polish 78.7 KB
2025-07-08 09:37
Major Shareholding Notification
Znaczne pakiety akcji - zmiana w ogólnej liczbie głosów. - Content (PL)
Polish 537 bytes
2025-07-05 15:54
Regulatory News Service
zal03_pdf_852875.pdf
Polish 4.5 KB

Automate Your Workflow. Get a real-time feed of all Synthaverse S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Synthaverse S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Galderma Group AG Logo
A dermatology company providing aesthetic, skincare, and therapeutic solutions worldwide.
Switzerland GALD
Genetic Analysis AS Logo
Develops microbiome diagnostics to detect gut dysbiosis for clinical and pharma partners.
Norway GEAN
GEN İLAÇ VE SAĞLIK ÜRÜNLERİ SANAYİ VE TİCARET A.Ş. Logo
Develops and manufactures pharmaceuticals for rare diseases and unmet health needs globally.
Türkiye GENIL
Genomtec S.A. Logo
Develops a mobile platform for rapid, precise genetic diagnostics at the point-of-care.
Poland GMT
Gentian Diagnostics ASA Logo
Develops & manufactures IVD immunoassays for human & veterinary disease diagnostics.
Norway GENT
GlaxoSmithKline PLC Logo
Develops vaccines and specialty medicines for infectious diseases, HIV, oncology, and immunology.
United Kingdom GSK
GNI  Group Ltd. Logo Japan 2160
Gour Medical Logo
Developed veterinary diagnostics and treatments for companion and production animals.
France MLGML
Grifols S.A. Logo
Develops plasma-derived medicines & biopharma solutions for rare and chronic conditions.
Spain GRF
Grindeks Logo
Pharmaceutical company developing and selling original/generic drugs & APIs globally.
Latvia GRD1R